Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Clinical trial NCT03025308 · COMPLETED
Trial details
- NCT number
- NCT03025308
- Sponsor
- Alfasigma S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2025-05-16
- Enrollment
- 2731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.